Jim Simons Pacific Biosciences Of California, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $2.69 Million - $4.55 Million	326,622 New	326,622 $2.73 Million
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $3.03 Million - $7.87 Million	-754,500 Reduced 86.85%	114,200 $505,000
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $7.32 Million - $18.2 Million	868,700 New	868,700 $7.91 Million
Q4 2021 Feb 11, 2022	SELL	$19.26 - $30.08 $5.27 Million - $8.24 Million	-273,800 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $13.6 Million - $19.2 Million	-547,000 Reduced 66.64%	273,800 $7 Million
Q2 2021 Aug 13, 2021	BUY	$22.3 - $36.02 $831,790 - $1.34 Million	37,300 Added 4.76%	820,800 $28.7 Million
Q1 2021 May 13, 2021	BUY	$26.38 - $51.15 $20.7 Million - $40.1 Million	783,500 New	783,500 $26.1 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.